topical intervention

Preclinical

TTanta University

topical intervention is one of 4 therapeutic programs targeting Acanthosis Nigricans. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Acanthosis NigricansCompleted

Acanthosis NigricansPreclinical

Completed

Competition

Competitive Landscape

4 competitors in Acanthosis Nigricans

#DrugCompanyPhaseTrials

Glucophage

EMD Serono

Approved

2 2

Rapamune

PPrism Pharmaceuticals

Approved

—3

Chromium Picolinate

PPennington Biomedical Research Center

Preclinical

1 4

topical intervention

TTanta University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Acanthosis Nigricans1 trial

Evaluation of the Efficacy and Safety of Systemic Metformin, Topical Metformin 30%, and Glycolic Acid 70% Chemical Peel in the Treatment of Patients With Acanthosis Nigricans: A Randomized Comparative Study

Completed·TTanta University·Preclinical·NCT07751549·54 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for topical intervention. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for topical intervention. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Tanta University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: TTanta University

topical intervention

Status by Indication[2][1]

Competitive Landscape

Trials by Indication[1]

Acanthosis Nigricans1 trial

References

Drug Info

Quick Facts

Related News